Innovation partners - VeViVas partners

Go to content

Innovation partners

Innovation partners consortia partners collaboration partners R&D service providers

Network overview
(the more expertise areas are shared between the partners, the thicker the connecting line gets)

Biochemistry


Biohemistry

Lipotype is the leading lipidomics service provider for every researcher. Our mass spectrometry-based technology identifies more than 2300 individual lipids in no time and routinely covers a rich variety of sample types while requiring only minimal sample amounts. Lipotype Shotgun Lipidomics empowers scientists from biotech, pharma, food industry, cosmetics and academia to reach their research goals through comparable, quantitative lipidomics data. Contact our research project support, order your lipidomics services, send in your samples and study your reports in as little as two weeks.
Lipotype GmbH
Tatzberg 47, 01307 Dresden, Germany
sales@lipotype.com
+49 (0)3517965345
Lipidomics
Shotgun Lipidomics
Lipids
Lipid profiling
Fatty acid analysis
Mass spectrometry
Analytics
Data analysis
GMP (good manufacturing  practice)
Bioinformatics
Data visualisation
Biomarker
Statistics

Biohemistry

OmicEra offers cutting-edge MS-based proteome analyses of human samples:
ranging from plasma, CSF or urine to FFPE and frozen tissue sections.
Robotic sample preparation assures high reproducibility and scalability for large discovery projects.
High end software solutions enable robust statistical analysis, including machine learning and information extraction for biomarker discovery.
OmicEra Diagnostics GmbH
Behringstr. 6, 82152 Planegg, Germany
Dr. rer. nat. Sophia Doll
Mass spectrometry
LC-MS
Protein analytics
Proteome analytics
Biomarker
Biomarker discovery
Proteome High throughput
 analytics
Robotic sample processing
Bioinformatics
Data analysis   

Bioreactors

Bioreactors


C-CIT Sensors AG is an innovative specialist in cell culture in-situ monitoring technology. It offers real-time process control systems based on in-situ glucose and lactate sensors suitable for all type of vessels and bioreactors. Automated process control systems reduce the risk of contamination, increase laboratory efficiency, reduce batch variability and cell stress.
C-CIT sensors as well as all the electronic components for data acquisition can be customized and integrated in different applications and systems.
C-CIT Sensors AG
Einsiedlerstrasse 34, 8820 Wädenswil, Switzerland
sales@c-cit.ch
+41 (0)43 477 85 55
Automated Process   control
In-situ sensors
Automation
Glucose sensors
Lactate sensors
Sensors
Process control system
Cell culture
Process probe
Ion selective electrodes
Ion selective membranes
Ion selective sensors
Metabolites
Cell culture monitoring
Flow cell
Reactor probes
Cap sensors
OEM Solutions
Industry 4.0
Bluetooth communication

Chemistry

Chemistry


ChemCon is a CDMO with profound experience in manufacturing of APIs for clinical trials.
We offer cGMP compliant APIs and medical polymers, process scale-up and synthetic route development.
Complementary services are available: CMC consulting, stability studies, analytical method development, identification of impurity profiles, reference standards, impurities.
We are experienced with “highly potents” and legally controlled narcotics. Our facilities are approved by the US FDA and the European authorities.
ChemCon GmbH
Engesserstr. 4b, 79108 Freiburg i. Br., Germany
Reinhard Hirsch
info@chemcon.com
+49 (0)761 5597443
Chemical syntheses
Analytics       
GMP (good manufacturing  practice)
Fine chemicals
Custom synthesis
Organic chemistry
Inorganic chemistry
Polymer Chemistry
Chemical development on  demand
Active Pharmaceutical
Ingredients (APIs)
ICH-compliant quality control
Release analytics
Contamination clarification
Reference Standards
Regulatory consulting
Cytotoxic substances
"BtMG" (narcotics) regulated  substances
Quality Control
Method development
Method validation
Structural elucidation
Stability Studies
Microbiological controls
Chemistry


Esy-Labs is an innovative spin-off of the Gutenberg-University of Mainz and of the Fraunhofer Society, specialized in the use of electrosynthesis technology for the production of organic and inorganic raw materials.
Electrosynthesis is available at a scale ranging from grams up to a few tons per year, while it is complemented by integrated biotechnological and chemical-catalytical sub-steps. This integration level results in a unique portfolio of Esy-Labs GmbH.
Founded in 2018, the company operates at the intersection of renewable energy production and chemical conversion. It offers customer-oriented consulting services, electrosynthetic synthesis on demand as well as process development. Thereby, Esy-Labs is able to provide customers electrosynthesis and electrocatalysis technology as needed.
ESy-Labs-GmbH
An der Irler Höhe 3a,
93055 Regensburg , Germany
Dr. Tobias Gärtner
info@esy-labs.de
+49 (0)941 94686 700
Design
Electro-catalysis
Electro-synthesis
Fine chemicals
Inorganic chemistry
Organic chemistry Pharmaceutical substances
Process development
Raw materials
Recycling
Renewable energy  

Drug development

Drug development


Eleva is a drug development specialist that has pioneered the production of biologics using the unique properties of Bryophyta (moss). Moss plants are not only able to produce the most complex and demanding proteins; with their unique characteristics, they virtually invite easy, stable engineering and reliable output. Eleva's technology enables tailored glycosylation for efficient organ uptake of biologics. Flexible genetic engineering and pathogen-free protein production are further advantages of the moss system. Eleva cooperates with pharmaceutical partners for the pre-clinical and clinical development of  therapeutic proteins.
eleva GmbH
Hans-Bunte-Str. 19, 79108 Freiburg, Germany
hello@elevabiologics.com
+49 (0)761 470 99 0
Antibody Dependent   Cell-mediated Cytotoxicity (ADCC) Biobetters
Biochemistry
Biologics
Bryophyta
Complement
Drug candidates
Enzymes
Expression systems
Fusion toxins
Genetics
Glycans
Glycosylation
LSD (Lysosomal storage diseases ) enzymes
Moss
Vaccines
Virus-like particles  (VLPs)
Drug development



IntiQuan provides comprehensive pharmacometric analyses and strategic consulting to help drug companies to optimize study designs, take more informed decisions and develop better medicines.
Pharmacometric analyses aim at providing an integrative and quantitative view of available knowledge and current status to support development of a compound and facilitate the decision-making process and regulatory interactions & filings. In preclinical phases up to Phase 3 questions center mostly around dose & regimen selection and study design optimization. After Phase 3 analyses focus on regulatory submission support, considering both the dose/concentration and the concentration/response relationships.
Strategic services focus on Clinical Pharmacology, Drug Development Strategy, and Regulatory Advice & Interactions.
IntiQuan GmbH
Elisabethenstrasse 23, 4051 Basel, Switzerland
Henning Schmidt

info@intiquan.com

+41 76 603 28 06
Clinical drug development
Preclinical drug
development
Data analysis
Pharmacometrics
Pharmacokinetics
Pharmacodynamics
Modeling
Simulation
Trial simulation
Clinical pharmacology
Non-compartmental analysis  (NCA)
Physiologically-based PK  (PBPK)
Quantitative Systems
Pharmacology   (PB-QSP)
Model-based meta analysis Utility analysis
Regulatory consulting
Submission support
Regulatory consulting
Consulting
Drug development



The Jagiellonian Centre for Experimental Therapeutics is a research unit of the Jagiellonian University in Krakow, Poland. Based on unique expertise and R&D tools, JCET collaborates with biotech/pharma companies and academia to develop endothelium-targeted pharmacotherapies of various diseases.
JCET develops a unique panel of assays to evaluate the effects of compounds on endothelium and blood vessels. Such endothelial profiling allows for searching for and validating of pharmacological mechanisms in the endothelium and vascular wall. Endothelial assays can also be used for evaluation of the vascular safety of novel drug candidates.
Service offers include:
1) Preclinical evaluation of endothelial/vascular safety
JCET applies models of endothelial inflammation, leukocyte adhesion, endothelial viability, and metabolism to screen for endothelial toxicity. JCET also provides in vivo methodology with multiple endpoints to assess the effects of compounds on endothelial/vascular function in various animal models and profiling for pro- and antithrombotic effects
2) High-content efficacy studies in relevant in vivo models – e.g. cardiovascular: JCET offers a wide range of in vivo efficacy studies in models of heart failure, atherosclerosis, pulmonary hypertension, non alcoholic fatty liver disease (NAFLD), hepatitis, thrombosis and cancer metastasis with comprehensive assessment of multiple endpoints, including in vivo imaging and concurrent evaluation of endothelial effects.
3) Analytical capabilities – pharmacokinetic studies and beyond
JCET has established methodology for screening of novel compounds in terms of their physicochemical parameters, pharmacokinetic profile, DME properties, bioavailability, percent of binding and absorption rate. Services also include metabolic profiling, metabolite identification, CYP450-dependent metabolism assays, as well as compound elimination studies. JCET also offers development and validation of bioanalytical methods.
The JCET facility is GLP-accredited over a broad range of laboratory methods and protocols.
Jagiellonian Centre for Experimental Therapeutics
Jagiellonian University in Krakow
ul. Bobrzyńskiego 14, 30-348 Krakow, Poland
jcet@jcet.eu
+48 (0)12 6645464
Preclinical drug   development
Pharmacology
In vitro assays
In vivo assays
Ex vivo assays
Animal models
GLP
Endothelium
Vascular wall
Toxicity assays
Endothelial inflammation
Endothelial viability
Endothelial safety
Endothelial metabolism
Efficacy studies
Atherosclerosis models
Heart failure models
Hepatitis models
Leukocyte adhesion
Vascular safety
Vascular toxicity
Drug development


ValiRx selects and incubates promising novel drug candidates for treatments of cancer and women's health indications. The company's scientists, business specialists and technologists provide a framework for effective drug development from pre-clinical to clinical studies, generating investor-ready assets.
ValiRx
Eliot Park Innovation Centre
4 Barling Way
Nuneaton, CV10 7RH
UK
Women's health
Women's diseases
Cancer
Oncology
Cancer therapy
Drug development
Drug candidates
Preclinical drug development
Clinical drug development
In-licensing
Out-licensing
Lead optimization
Biomedical innovation Financing Consulting

Engineering

Engineering



Enventiios is an innovative small entrepeneur that develops and builds special machines and apparatuses on behalf of its customers. The enventiios team has profound expertise in the development of energy storage solutions, tecnical Innovations and special mechanical engineering.
enventiios UG
Klaepenheide 29, 29585 Jelmstorf, Germany
info@enventiios.de
Mechanical Engineering
Renewable energy
Thermochemical heat  storage
Compressed air storage
Energy storage
Process engineering
Product development
Design
Special apparatus  engineering
Special machinery
construction
Plant engineering
Small reactors
Centrifugation
Transformers
Absorption drying
Start-up coaching
Innovation coaching
Training
Engineering

Dr. Tom Marr

Dr.-Ing. Tom Marr is a freelance engineer, located in Dresden/Germany.
He offers services to companies and engineering service providers.
His expertise includes:
Product development
Simulation (specialized in fluid dynamics simulation and thermal transport challenges)
Product design
Materials testing
Grant acquisition
Software used in his work includes: FloEFD, SolidWorks Flow Simulation, ANSYS Fluent/CFX, SolidWorks
Dr. Tom Marr
Malterstraße 30, 01159 Dresden, Germany
info@tom-marr.de
+49 (0)176 379 77 083
Design
Energetical optimization Energy efficiency
Grants
Materials testing
Product development Simulation   


Engineering


MOZYS Engineering GmbH develops complete solutions for Industrial IoT, e.g. for predictive maintenance and condition monitoring applications. A particular area of expertise lies in the field of vibrations.
Hardware, software and engineering from a single source: this makes it easier for customers to get started with sensor-based monitoring applications and opens up new solutions and business models in the context of Industry 4.0 based on unique performance features. Customers are supported from the initial idea to series production and benefit from short development times and high flexibility enabled by a modular platform strategy. All products are available as OEM versions and provide the basis for customer-specific developments.
MOZYS Engineering GmbH
Friedrich-Bergius-Ring 15,
97076 Würzburg, Germany
Dr. Amin Mozaffarin
a.mozaffarin@mozys.de
+49 (0)931 49 739 209 1
Brownfield
Cloud connectivity
Cloud services
Condition Monitoring
Connectivity
Data visualisation
Datalogger
Device Management
Edge Computing
Electrical engineering
End-to-end connectivity
Fieldbus systems
Hardware development
I/O interfaces
Industrial Ethernet
Industry 4.0
Internet platforms
IoT (internet of things)
IoT-Gateways
Predictive Maintenance
Product development
Sensor systems
Software development

Informatics / data science

Informatics / data science


BotCraft is a highly specialized software development company in the field of machine connectivity, robotics and process automation that develops secure solutions for intelligent production and quality assurance.
BotCraft GmbH
Lichtenbergstraße 8, GaTe Garching
85748 Garching bei München
Germany
info@botcraft.de
+49 (0)8168/4290519
AI (artificial   intelligence)
AIoT (Artificial Intelligence of Things)
Bots
Brownfield
Edge Computing
End-to-end connectivity
Industry 4.0 IoT (internet of  things)
iRPA (intelligent robotic  process automation)
Predictive Maintenance Process automation
Robotics
Software architecture  development
Software development
Informatics / data science


VeViVas provides  two types of services to business clients in the pharma/biotech and greentech industry (B2B):
I) Open innovation: we identify expert service providers and assemble consortia or expert teams to work on innovation tasks of our clients.
II) In depth analysis and visualization of complex information, e.g. derived from transcriptome- or pharmacogenetic data. Biomarker analyses for precision medicine as well as machine learning approaches and statistical analyses are also part of our portfolio.
VeViVas GmbH
Im Homburg 31, 79539 Lörrach, Germany
Dr. Arndt Brachat
info@vevivas.com
+49 (0)76211616066
Bioinformatics
Biomarker
Clinical drug development Clinical statistics
Data science
Data visualisation
Diagnostic algorithms
Diagnostic biomarkers Diagnostics
Diagnotic subtypes
Drug response prediction Endotype discovery Exploratory data analysis Genetics
Open innovation
Patient stratification Personalized medicine Pharmacodynamic markers Pharmacogenomics
Precision medicine

Materials

Materials


The company is the leading manufacturer of highly-ordered porous membranes from alumina and silicon with defined and adjustable properties and structure parameters. SmartMembranes not only manufactures membranes on customers‘ request, we also develop new processes and products around our core business. We are a spin-off from the Fraunhofer Institute for Mechanics of Materials, hence we work closely with that research institute as well as with the Martin-Luther University Halle-Wittenberg and the Max-Planck Institute for Micro Structure Physics in Halle/Germany.
Products:
SmartMembranes produces macro- und nanoporous structures from silicon and alumina.
Our standard products SmartPor and MakroPor are characterized by a highly ordered structure and a low standard deviation of the pore diameter. Structural parameters such as pore size, lattice constant, porosity and membrane thickness can be adjusted at the nanometer level according to customer needs. The products can be further customized in collaboration with our clients. Surface functionalization (silanization) enables, for example, the control of the hydrophobicity / hydrophilicity of the pores. The membranes can also be used as templates for the development of new nanostructures. The galvanic deposition of metals or metal oxides or polymer wetting expand the possibilities for the production of defined nanotubes and nanorods.
Potential applications can be found in the fields of filtration, sensor technology and diagnostics ("biochips"). The membranes serve as electrode material in battery development and in fuel cells or are used as an anti-reflective surface in optics.
SmartMembranes GmbH
Heinrich- Damerow- Str. 4,
06120 Halle (Saale), Germany
petra.goering@smartmembranes.de
+49 (0)345 13514386
monika.lelonek@smartmembranes.de
+49 (0)345 13517453
Catalysts
Diagnostics
Filtration
Membranes
Microfluidics
Microreactors
Nanostructure   


Microbiology

Microbiology


As a pioneer in the cultivation of microalgae, Algomed has developed a unique cultivation method. An extensive glass tube system inside greenhouses allows optimal lighting and control of the growth conditions. Algomed cultivates various microalgae species as a supplier to the food, feed and cosmetics industries. For research and development projects in the fields of circular- and bio-economy, the microalgae specialist also contributes its expertise.
Algomed / Roquette Klötze GmbH & Co. KG
Lockstedter Chaussee 1,
38486 Klötze, Germany
info@algomed.de
+49 (0)39 09 47260
Microalgae
Algae
Chlorella vulgaris
Phototropic microarganisms
Microbial production
Phytoextracts
Plant extracts
Biomass
Greenhouses
Bioreactors
Circular economy
Bioeconomy
Cell culture
Food production
Animal feed production Product development
Microbiology


The products and services of IGV PLANTTECH are based on 30 years of experience of research and development in the cultivation of phototrophic microorganisms, such as microalgae, cell and tissue cultures. IGV PLANTTECH has developed into a reliable and professional technology provider and supplier in this field for universities, research institutes and research departments in companies of various sizes.
The employees - scientists, engineers, designers and technical staff - have many years of extensive knowledge in phototrophic biotechnology and offer, for example, experience in research and characterization of active substances, process and product development as well as photobioreactor design.
The core objective of IGV PLANTTECH is the technical generation of active substances and raw materials in the fields of cosmetics, chemical industry, energy industry, environmental technology, agriculture, healthy nutrition and functional food.
In addition,  processing technologies and procedures are developed to production stage and applied in pilot scale. In all these developments, research results from biology, biochemistry and high-end process engineering are profitably and efficiently combined with the latest findings in the physiology of phototrophic microorganisms.
IGV GmbH
Arthur-Scheunert-Allee 40-41,
14558 Nuthetal, Germany
Dipl.-Chem. Petra Sandau
petra.sandau@igv-gmbh.de
+49 (0)33200 89 257
Cell culture
Chlamydomonas
Feasibility studies
Galdieria
Haematococcus
Microalgae
Microbial production  
Nannochloropsis Phaeodactylum Photobioreactor
Phototrophic bacteria Phototropic microarganisms Phytoextracts
Plant extracts
Porphyridium
Process development Scenedesmus

Molecular biology

Molecular biology


As a global pioneer in custom DNA vectors and recombinant viruses, VectorBuilder’s revolutionary online-to-offline (O2O) platform provides a powerful one-stop solution to all the vector and virus needs in the life sciences.
VectorBuilder has a wide spectrum of offerings, including:
Vector design, Custom cloning, Virus packaging, Library construction, BAC recombineering, Mutagenesis, Stable cell line generation and more ...
Additionally, our state-of-the-art GMP facilities provide GMP-grade vector manufacturing for a wide range of clinical applications.
VectorBuilder GmbH
Hermannstr. 54-56, 63263 Neu-Isenburg, Germany
service@vectorbuilder.com
+49 (0)61022486890
Viral vectors
Viral packaging
COVID-19 Corona virus  solutions
Libraries
Library Construction
Vector Cloning
BAC Recombineering
Plasmid DNA Preparation
Mutagenesis (for Vectors)
Cell line development
Baculovirus
Lentivirus
Adeno-Associated Virus (AAV)
Adenovirus
Retrovirus
AAV
Serotype Testing
CRISPR Genome Editing
Inducible Gene Expression
shRNA Gene Knockdown
Molecular biology


ATG:biosynthetics is an experienced specialist in synthetic biology. The company provides services in gene design, optimization and synthesis. Multiparametric bioinformatics methods are used for fast optimization of single and multigenic DNA sequences, generating species-specific, customized constructs. In addition, ATG:biosynthetics offers peptide construction and expression solutions.
ATG:biosynthetics GmbH
Weberstraße 40, 79249 Merzhausen, Germany
Dr. Hubert Bernauer
+49 (0)1796607141
Stefanie Bernauer
+49 (0)7618889424
Synthetic biology
Synthetic genes
Gene operon design
Gene cluster design
Gene optimization
Gene synthesis
Multi-gene expression
Multi-protein expression
Heterologous expression
Bioinformatics of gene
 expression
Bioinformatics of enzyme
 engineering
Bio-assay development
Fast antibody develpment
Biodesign
Biosensor
Peptide libraries
Peptide expression
Sub-cloning service
Comparative omics analyses
FlexTEC (modular, compatible
 vector system)
FlexMAM - modular,
 compatible vector system for
 mammalian cells
HDPMA
 (high density peptide
 microarrays)
HDPMA - epitope screening
HDPMA screening for specific
 peptide binders of small
 chemical sructures
tANCHOR - mammalian
 protein display system
Vaccine development on
 tANCHOR basis
Vaccines

Nanotechnology

Nanotechnology


lino Biotech is the world´s only provider of Focal Molography – a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells. Molography allows to measure molecular interactions in a more robust and more sensitive way while offering unique information for cell-based assays. This broadly patented technology offers label-free detection assays using the power of molecular diffraction while eliminating disturbances of environmental factors such as changes in temperature or non-specific binding. Understanding these signaling pathways forms the basis for pharmaceutical drug development.
lino Biotech AG
Gloriastrasse 35, 8092 Zurich, Switzerland
Dr. Mirko Stange, CEO
info@lino-biotech.com
Focal Molography
Biomolecular interactions
Cell-based assays
In vivo assays
Label-free detection
Real time interactions
Biosensor
Mologram
Diffractometric biosensors
Molecular diffraction
Drug-target interactions
Drug development
Imaging
Sensor systems
Sensors
Diagnostic biomarkers

Plant engineering

Plant engineering


RAPIDFACTURE enables the rapid production of precision components for mechanical and plant engineering. With the portal ''Production Online'' the company offers online CAD as well as the production of components for the processes milling and turning (1 - 50.000 pieces) including all common further processing like hardening, anodizing or grinding. In addition, RAPIDFACTURE also produces welding assemblies. The automation and digitalization of production processes is supported by software products and customer-specific software development.
RAPIDFACTURE GmbH
Max-Planck-Str. 7
85716 Unterschleißheim
Germany
info@rapidfacture.com
+49 (0)89 215 40180
Autonomous production Computer-aided design (CAD) Computer-aided manufacturing (CAM)
Design
Industry 4.0
Mechanical Engineering
Mechatronics
Metalworking
Milled parts
Online CAD
Online design
Online production
Part design
Part production
Plant engineering
Precision parts
Production software
Prototype production
Shop systems
Turned parts

Legal / Consulting / Funding

Legal / Consulting / Funding
Patrik Scholler ist a seasoned well-networked consultant with long-standing experience in the Life Sciences industries, both in startup and international corporate environments. He supports clients with excellent expertise in strategic decision-making and execution in corporate and business development. Among his priorities are the interface of high-tech/IT and cross-healthcare system challenges .
LIFE SCIENCES CONSULTING
Henri-Dunant-Str. 1
63500 Seligenstadt
Germany
lifesciences-consulting@gmx.de
+49( 0)6182 948 1351
Consulting
Life sciences
Market Analysis
Competitive Analysis
Start-up Consulting
Business plan preparation
Business Development
Commercialization of  innovations
Team Setup
Strategic Planning
Financing consulting

Portfolio Management
Interim Management
Marketing & Sales
Search for specialists
Executive search

Complementary skills

Complementary skills


CO2OP helps companies to assess  and reduce their greenhouse gas emissions. CO2OP works with a network of energy consultants to define suitable reduction measures. In doing so, economic aspects are always kept in mind.
In addition, the company helps to compensate for unavoidable emissions.
CO2OP
Climate neutrality
Emission reduction Greenhouse gas balance
GHG
GHG protocol
ISO 14064-1
Climate protection
Scope 1,2,3
Energy consulting
CO2 footprint
Emission compensation
Offset projects
Clean Development
Mechanism
Sustainable Development  Goals
System boundaries
Indirect emissions
Carbon dioxide CO2
Methane CH4
Nitrous oxide N20
    CO2 - neutral     VeViVas uses CO2-emission-free hosting services, electricity and heating      
Subject to technical changes and printing errors. Copyright (c) 2021 VeViVas
Back to content